News
Neurologist Dr. Leah Croll talks about the new research suggesting they might help in treating people with alcohol use ...
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) can lead to significant weight loss and improve blood sugar control in ...
According to a recent Kaiser Family Foundation poll, roughly 6% of U.S. adults are currently taking GLP-1 for weight loss, ...
Some users of GLP-1 weight-loss drugs have been reporting strange changes in food preferences, such as a new dislike for ...
GLP-1 analogues, typically prescribed for weight loss, led to a 68% reduction in alcohol intake among regular drinkers.
People with mental health problems could be prioritised for weight loss jabs, experts have suggested, after a study showed ...
Some of the bankrupt company’s closest rivals, newer telehealth firms, face a new challenge of their own as federal ...
Background Pre-clinical data demonstrates the ability of Exenatide, a GLP-1R agonist, to reduce CSF secretion and ICP.1 Existing GLP-1R agonists are widely used to treat obesity and diabetes (but do ...
Research presented at the the European Congress on Obesity suggests weight loss injections are safe and work for the mentally ...
The weight-loss drug revolution is reshaping the health and wellness industry, forcing companies to adapt or face the same ...
New research presented at the European Congress on Obesity (ECO 2025) and published in the journal Diabetes, Obesity and ...
A MOTHER has revealed that she was unhappy and tired of dieting so decided to start using Mounjaro. In just 16 weeks, thanks to the injections, Jade-Jo was able to lose 2 stone 4 lbs. But Jade-Jo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results